Vice President, Research


Heather is leading research discovery and development at NuMedii, successfully translating AI hits into novel therapeutics. She has more than 15 years of experience in large and small molecule drug discovery and development, and more than 30 publications in top-tier journals with research focused on diverse pathways in immunology, neuroscience, and fibrotic diseases. In her most recent role at Amgen, Heather spearheaded multiple immune modulatory therapies, as well as building and managing a robust team of scientists and associates focused on filling the pipeline with new therapies for fibrotic and inflammatory diseases, and immuno-oncology. She holds a PhD in Neuroscience from the University of North Carolina at Chapel Hill and completed a National Multiple Sclerosis Society postdoctoral fellowship at Harvard Medical School and the Dana-Farber Cancer Institute.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement